Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1750 attorneys serving clients from 36 offices in the United States, Latin America, Europe, the Middle East and Asia. Greenberg Traurig is among the Top 10 law firms on The National Law Journal's 2013 NLJ 350, an annual ranking of the largest firms in the U.S. For additional information, please visit www.gtlaw.com.
Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. Its services include antitrust counseling and litigation, corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. Its accomplished team of antitrust attorneys is uniquely positioned to assist clients on the most important bet-the-company matters, as well as with regular counseling and compliance matters, and represents enterprises in merger and anticompetitive conduct matters in the United States and before Asian and European competition authorities. WSGR’s accomplished team is consistently recognized among the leading antitrust practices in the United States.
Winston & Strawn LLP is an international law firm with more than 850 attorneys among 18 offices in Beijing, Brussels, Charlotte, Chicago, Geneva, Hong Kong, Houston, London, Los Angeles, Moscow, New York, Newark, Paris, San Francisco, Shanghai, Silicon Valley, Taipei, and Washington, D.C. The exceptional depth and geographic reach of our resources enable Winston & Strawn to manage virtually every type of business-related legal issue. We serve the needs of enterprises of all types and sizes, in both the private and the public sector. We understand that clients are looking for value beyond just legal expertise. With this in mind, we work hard to understand the level of involvement our clients want from us. We take time to learn about our clients’ organizations and their business objectives. And, we place significant emphasis on technology and teamwork in an effort to respond quickly and effectively to our clients’ needs. Visit winston.com if you would like more information about our legal services, our experience, or the industries we serve.
Antitrust - Asia competition and regulatory
Winston & Strawn has extensive experience advising multinational companies in connection with merger reviews in numerous Asian jurisdictions, including China, Japan, Korea, and Taiwan, as well as in connection with government investigations and litigation. Through our offices in the Asia-Pacific region, as well as through our experienced practitioners based in the U.S., we are frequently involved in leading merger and cartel cases and investigations. While many of these cases run parallel to related proceedings in the United States, EU, and other jurisdictions we have mastered successful coordination to ensure an efficient and consistent worldwide approach with proven results
Economists Incorporated is a premier economic consulting firm in the fields of law and economics, public policy, and business strategy. Headquartered in Washington, D.C., EI offers expert consulting and testifying services in the context of litigation, arbitration, proposed mergers and acquisitions, regulatory hearings, and business planning. Its clients include legal counsel, businesses, trade associations, government agencies, and multilateral organizations. Since its founding in 1981, EI has participated in path breaking and high profile antitrust, commercial litigation, and regulatory matters. EI’s work has covered a large number of industries and multiple jurisdictions. EI’s Asia practice has focused primarily on work before antitrust enforcement agencies and courts in countries such as China and South Korea, and is led by highly experienced economists who speak the local language and understand the local market.
Dr. Weisun Rao focuses his practice on intellectual property law and business law. He is experienced in developing IP strategies and building and managing IP portfolios for legal and business opportunities in the United States, China and elsewhere in the world. Additionally, Weisun also advises clients on monetizing and enforcing their IP rights throughout the world. He counsels clients on IP and business issues in the pharmaceutical, biotechnology, nutraceutical, medical device, advanced material and mechanical industries. Weisun is also experienced with due diligence and counter-diligence investigation, negotiating and drafting technology transfer agreements and licensing agreements, and providing patentability, validity, infringement, and freedom-to-operate opinions.
Weisun is involved in such business transactions as cross-border mergers and acquisitions. He is particularly experienced in advising non-Chinese clients on legal regulations and business practices in China and advising Chinese businesses interested in entering or expanding in the U.S. market.
Stuart Chemtob is Senior Of Counsel in WSGR’s Washington, D.C. office, where his Asia-oriented practice focuses on representing companies and individuals in criminal and non-criminal antitrust investigations in the United States and providing global strategic antitrust counseling. He has appeared before China’s National Development and Reform Commission on behalf of American companies that have been the subject of investigation. He previously served as Special Counsel for International Trade in the Antitrust Division, where he advised on international enforcement, mutual legal assistance and extradition matters, and was the Antitrust Division’s liaison to the antitrust enforcement agencies in Asia. Stuart was the lead Department of Justice official on relations with China’s antimonopoly agencies (MOFCOM, NDRC, SAIC), spearheading negotiation of the U.S.–China MOU on Antitrust Cooperation and providing advice and training to the Chinese government on the drafting and implementation of the Antimonopoly Law.
Steve Harris is a partner in the firm’s Washington, D.C. and New York offices and concentrates his practice in antitrust/competition law, including litigation, cartel defense, merger control filings, and administrative proceedings before U.S. and international courts and agencies. He has particular experience working with clients in China, Korea, Japan, and Taiwan.
Mr. Harris’ representative matters include:
- Represented a major U.S. consumer products company in antitrust cartel investigation and follow-on class action litigation.
- Represented a European chemicals manufacturer in antitrust cartel investigation in the United States and EU, and in follow-on class action litigation.
- Represented a leading personal computer manufacturer in an antitrust and patent infringement action involving MPEG data compression technology.
- Represented a major international airline before antitrust and regulatory agencies in Asia and the United States in a successful global effort to retain its multi-year joint business agreement with one of Asia Pacific’s leading airlines.
- Represented a leading U.S. biotechnology company in worldwide antitrust and merger control issues related to USD500 million acquisition by European multinational crop science company. This matter was granted early termination by the U.S. Department of Justice Antitrust Division.
- Represented Prestige Brands Holdings Inc. in the worldwide antitrust and merger control issues related to its USD660 million acquisition of the over-the-counter pharmaceutical brands business of GlaxoSmithKline, Prestige’s largest acquisition ever. The matter involved two transactions and interesting issues under the U.S. Federal Trade Commission’s aggregation rule; the FTC granted early termination.
- Represented a leading global information services company in worldwide antitrust and merger control proceedings; the merger presented several unusual competition law issues, including the application of the “media merger” rules in Germany and Austria.
- Represented a leading specialty minerals company based in France in the U.S. antitrust and merger control issues related to its USD665 million acquisition of a talc business.
- Represented a leading global medical technology company in the worldwide antitrust and merger control proceedings in its acquisition of a Swedish company involving issues related to complementary versus competitive products in several jurisdictions.
- Represented a leading multinational resources company in the review of a joint venture with another large resources company under the China Anti-Monopoly Law.
Mr. Harris received his A.B., magna cum laude, from Cornell University in 1977. He received his J.D. from Columbia Law School in 1982, where he was certified with honors by the Parker Program in Foreign and Comparative Law, and was a Harlan Fiske Stone Scholar.
Dr. Su Sun is a Vice President at Economists Incorporated. He specializes in economic analysis in antitrust and regulatory matters. He has conducted economic analysis for antitrust review of mergers before the U.S. Department of Justice and Federal Trade Commission, Canadian Bureau of Competition, and China’s Ministry of Commerce. He has also worked on estimation of damages in a number of price fixing cases, and has provided analysis in some abuse of dominance cases, including those involving bundled discounts, exclusionary practices and the licensing of patents.
Dr. Sun has written extensively on antitrust issues, particularly those pertaining to China, both in English and in Chinese. He is a Senior Editor of the Antitrust Law Journal, a member of the American Economic Association, and a member of the Chinese Economists Society. Dr. Sun earned his Ph.D. in economics from the University of Michigan and his B.A. from Renmin University of China.